Elevated levels of CHI3L1 have been observed in several chronic inflammatory diseases, including asthma, where it is thought to contribute to disease pathogenesis through its effects on immune cell recruitment, tissue remodeling, and fibrosis (19–22). Here, CHI3L1 is linked to asthma.